肽
分子模拟
化学
血凝素(流感)
病毒
抗体
脂质双层融合
计算生物学
甲型流感病毒
2019年冠状病毒病(COVID-19)
病毒学
膜
生物化学
肽序列
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
蛋白质结构
蛋白质设计
生物
拟肽
结合亲和力
细胞生物学
血浆蛋白结合
肽库
膜蛋白
融合蛋白
蛋白质-蛋白质相互作用
结合位点
构象变化
2019-20冠状病毒爆发
氨基酸
双特异性抗体
作者
Rameshwar U. Kadam,Jarek Juraszek,Davide Branduardi,Jeroen van Ameijde,Divita Garg,Jan Vermond,Mandy A. C. Jongeneelen,Chan Tang,Ronald Vogels,Maria J. P. van Dongen,Boerries Brandenburg,Robert H. Friesen,Ian A. Wilson
标识
DOI:10.1021/acsmedchemlett.6c00321
摘要
Abstract Here we report the applicability of a hotspot-centric approach for de novo computational design of l-peptides based on crystal structures of antigen–antibody complexes. Broadly neutralizing antibodies (bnAbs) FI6v3 and CR9114, which target influenza A virus hemagglutinin (HA), guided the peptide design. Disembodied hotspot residues from these bnAbs were selected and anchored onto known peptide scaffolds (≤35 amino acids) from the Protein Data Bank (PDB). The top-scoring designs were subsequently synthesized, folded, tested in vitro, and structurally characterized in complex with HA. The designed peptides demonstrate structural and functional mimicry by recapitulating the binding mode of the bnAbs on HA and act as inhibitors of low-pH-dependent conformational transitions in HA that facilitate membrane fusion. These findings demonstrate that hotspot-guided design strategy, previously applied to proteins and d-peptides, can be effectively extended to l-peptide scaffolds, enabling the development of functional HA inhibitors informed by key residues at antigen–antibody interfaces.
科研通智能强力驱动
Strongly Powered by AbleSci AI